Ansbert Gadicke, 10% Owner at Repare Therapeutics Inc. (RPTX), sold 112,198 shares at $30.74 ($3.6M) on 2021-06-07, disclosed to the SEC on 2021-06-07.
Open-market sale of $3.6M RPTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.92 | 22,296 | $712K | 19.8% |
| 2 | $31.92 | 22,296 | $712K | 19.8% |
| 3 | $30.80 | 8,042 | $248K | 6.9% |
| 4 | $30.80 | 8,042 | $248K | 6.9% |
| 5 | $31.28 | 4,694 | $147K | 4.1% |
| 6 | $31.28 | 4,694 |
| $147K |
| 4.1% |
| 7 | $30.74 | 2,400 | $74K | 2.1% |
| 8 | $32.25 | 1,700 | $55K | 1.5% |
| 9 | $32.96 | 19,017 | $627K | 17.4% |
| 10 | $32.96 | 19,017 | $627K | 17.4% |
| Total | $32.04 avg | 112,198 | $3.6M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |